ADDPI 2023_05 INADA vs Ajay Kumar

Related case:

ADAPI 2023_27 Ajay Kumar vs INADA
September 4, 2023

In February 2023 the India National Anti-Doping Agency (INADA) reported an anti-doping rule violation against the volleyball player Ajay Kumar after his sample tested positive for the prohibited substance Dehydrochlormethyltestosterone.

Following notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the Anti-Doping Disciplinary Panel of India (ADDPI).

The Athlete admitted the violation and denied the intentional use of the substance. He alleged with evidence that he had received medical treatments in hospitals for his condition and had used prescribed medication that probably contained the prohibited substance.

INADA contended that the Athlete failed to demonstrate with corroborating evidence that the violation was not intentional, nor the source of the prohibited substance whereas had acted negligently.

The Panel finds that the presence of a prohibited substance has been established in the Athlete's sample and accordingly that he committed an anti-doping rule violation.

In view of the evidence Panel deems that the Athlete's medical information and prescribed medication did not identify the source of the prohibited substance, nor that the violation was not intentional.

Therefore the Panel decided on 5 July 2023 to impose a 4 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 22 Februar 2023.

Original document

Parameters

Legal Source
National Decisions
Date
5 July 2023
Arbitrator
Mukerji, Abhinav
Singh, Prashanti
Singh, Vivek Pal
Original Source
India National Anti-Doping Agency (INADA)
Country
India
Language
English
ADRV
Adverse Analytical Finding / presence
Legal Terms
Admission
Case law / jurisprudence
Circumstantial evidence
Negligence
Sport/IFs
Volleyball (FIVB) - International Volleyball Federation
Other organisations
Anti-Doping Disciplinary Panel of India (ADDPI)
India National Anti-Doping Agency (INADA)
Laboratories
New Delhi, India: National Dope Testing Laboratory
Doping classes
S1. Anabolic Agents
Substances
Dehydrochlormethyltestosterone (4-chloro-17β-hydroxy-17α-methylandrosta-1,4-dien-3-one)
Medical terms
Legitimate Medical Treatment
Document type
Pdf file
Date generated
19 September 2023
Date of last modification
28 September 2023
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin